AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 139 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $22,698,000 | +44.5% | 1,500,183 | -28.4% | 0.04% | +58.3% |
| Q2 2022 | $15,711,000 | -26.6% | 2,094,811 | -10.9% | 0.02% | -14.3% |
| Q1 2022 | $21,403,000 | +125.3% | 2,351,994 | +73.8% | 0.03% | +133.3% |
| Q4 2021 | $9,498,000 | -37.5% | 1,352,954 | +1.5% | 0.01% | -47.8% |
| Q3 2021 | $15,196,000 | -32.2% | 1,332,964 | -4.7% | 0.02% | -17.9% |
| Q2 2021 | $22,404,000 | -11.2% | 1,399,345 | -0.9% | 0.03% | -15.2% |
| Q1 2021 | $25,223,000 | -33.5% | 1,411,454 | -49.7% | 0.03% | +22.2% |
| Q4 2020 | $37,908,000 | +176.4% | 2,805,950 | +144.9% | 0.03% | +22.7% |
| Q3 2020 | $13,714,000 | -16.7% | 1,145,675 | +2.7% | 0.02% | -26.7% |
| Q2 2020 | $16,473,000 | +24.5% | 1,116,038 | +1.2% | 0.03% | +7.1% |
| Q1 2020 | $13,231,000 | -50.3% | 1,102,603 | +0.0% | 0.03% | -34.9% |
| Q4 2019 | $26,643,000 | +132.3% | 1,102,336 | +134.0% | 0.04% | +79.2% |
| Q4 2015 | $11,469,000 | +54.1% | 471,000 | +12.3% | 0.02% | +50.0% |
| Q3 2015 | $7,442,000 | -63.5% | 419,500 | -64.6% | 0.02% | -60.0% |
| Q2 2015 | $20,363,000 | +38.6% | 1,185,300 | +149.2% | 0.04% | +37.9% |
| Q1 2015 | $14,694,000 | +32.4% | 475,700 | +25.1% | 0.03% | +31.8% |
| Q4 2014 | $11,098,000 | -99.9% | 380,200 | -5.9% | 0.02% | +100.0% |
| Q3 2014 | $8,360,829,000 | -16.5% | 404,100 | 0.0% | 0.01% | -8.3% |
| Q2 2014 | $10,009,557,000 | +17.6% | 404,100 | +0.6% | 0.01% | +20.0% |
| Q1 2014 | $8,512,023,000 | +13.5% | 401,700 | -3.8% | 0.01% | +11.1% |
| Q4 2013 | $7,500,096,000 | – | 417,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|